Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy
暂无分享,去创建一个
Xin Niu | Xiaozheng Ling | Yang Wang | X. Niu | Haiyan Li | Qingwei Zhu | Qing Li | Yang Wang | Qing Li | Zhifeng Deng | Guowen Hu | Haiyan Li | Qingwei Zhu | Yunlong Yang | Juntao Zhang | Bi Chen | Yunlong Yang | Xiaozheng Ling | Juntao Zhang | Guo-wen Hu | Bi Chen | Zhifeng Deng
[1] Ying Fan,et al. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases. , 2018, Critical reviews in therapeutic drug carrier systems.
[2] J. Thomson,et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells , 2005, Nature Methods.
[3] V. Arena,et al. Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment , 2017, PloS one.
[4] Zhiyuan Zhong,et al. cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[5] Cao Xie,et al. RGD-modified lipid disks as drug carriers for tumor targeted drug delivery. , 2016, Nanoscale.
[6] Xin Hou,et al. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. , 2016, ACS nano.
[7] M. Hendrix,et al. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] L. Kheirandish-Gozal,et al. Plasma Exosomes Disrupt the Blood-Brain Barrier in Children with Obstructive Sleep Apnea and Neurocognitive Deficits. , 2017, American journal of respiratory and critical care medicine.
[9] Fei Wang,et al. GSH-Activated Light-Up Near-Infrared Fluorescent Probe with High Affinity to αvβ3 Integrin for Precise Early Tumor Identification. , 2018, ACS applied materials & interfaces.
[10] Jeffrey Wyckoff,et al. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles , 2018, Nature Communications.
[11] P. Zandstra,et al. Culture development for human embryonic stem cell propagation: molecular aspects and challenges. , 2005, Current opinion in biotechnology.
[12] J. Connor,et al. Exosomes and their implications in central nervous system tumor biology , 2019, Progress in Neurobiology.
[13] M. Amiji,et al. Exosome mediated communication within the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[14] Song Fan,et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. , 2018, Biomaterials.
[15] Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis , 2017, Stem Cell Research & Therapy.
[16] K. Ligon,et al. Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] M. Wood,et al. Exosomes for targeted siRNA delivery across biological barriers. , 2013, Advanced drug delivery reviews.
[18] Gary K. Schwartz,et al. Tumour exosome integrins determine organotropic metastasis , 2015, Nature.
[19] T. Wurdinger,et al. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[20] Wei Li,et al. Chemically Edited Exosomes with Dual Ligand Purified by Microfluidic Device for Active Targeted Drug Delivery to Tumor Cells. , 2017, ACS applied materials & interfaces.
[21] Bifeng Liu,et al. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis. , 2017, Nanoscale.
[22] M. Hendrix,et al. Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells , 2015, International journal of cancer.
[23] A. Seyfoori,et al. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response , 2017, Pharmacology & therapeutics.
[24] Mary J. C. Hendrix,et al. Reprogramming metastatic tumour cells with embryonic microenvironments , 2007, Nature Reviews Cancer.
[25] V. Mazzaferro,et al. Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[26] X. Niu,et al. Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. , 2017, Nanoscale.
[27] H. Lenz,et al. Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. , 2018, Journal of the American Chemical Society.
[28] Erwin G. Van Meir,et al. Overcoming therapeutic resistance in glioblastoma: the way forward. , 2017, The Journal of clinical investigation.
[29] Toshiaki Isobe,et al. Cell surface biomarkers of embryonic stem cells , 2008, Proteomics.
[30] B. Ratner,et al. Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature. , 2015, Advanced drug delivery reviews.
[31] M. Hendrix,et al. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. , 2009, Epigenomics.
[32] P. de Vos,et al. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors. , 2014, Advanced drug delivery reviews.
[33] M. Hendrix,et al. Lefty Glycoproteins in Human Embryonic Stem Cells: Extracellular Delivery Route and Posttranslational Modification in Differentiation. , 2016, Stem cells and development.
[34] R. Pedersen,et al. Culture of human embryonic stem cells , 2005, Nature Methods.
[35] Imre Mäger,et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.
[36] J. Arluzea,et al. Reprogramming of melanoma cells by embryonic microenvironments. , 2009, The International journal of developmental biology.
[37] M. Hendrix,et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells , 2008, Proceedings of the National Academy of Sciences.
[38] Q. Tang,et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. , 2018, Biomaterials.
[39] R. Schiffelers,et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[40] Lijia Huang,et al. Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs , 2018, Advanced science.
[41] Lalit N. Goswami,et al. cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI). , 2013, Inorganic chemistry.
[42] Ting-Yu Shih,et al. Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration , 2014, ACS nano.
[43] Richa Gupta,et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[44] Maria Ericsson,et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. , 2014, ACS nano.
[45] N. Neamati,et al. Current Challenges and Opportunities in Treating Glioblastoma , 2018, Pharmacological Reviews.